See all our reports on Bausch Health Companies.

  1. Position Update: Long Idea and Danger Zone Research – published 5/22/17
  2. Misaligned Incentives That Led To Valeant Disaster Go Unaddressed – published 4/13/16
  3. Today’s 40% Drop Is Not Enough For Valeant Pharmaceuticals – published 3/15/16
  4. Danger Zone: Valeant Pharmaceuticals (VRX) – published 2/29/16
  5. Cutting Through Valeant’s Story – published 6/30/14
  6. Don’t Be Fooled: The Euro Will Take Us All Down – published 12/6/11